跳至主要内容
临床试验/NCT07602010
NCT07602010招募中不适用

Prospective Diagnostic Accuracy Study Comparing CT and MRI (VI-RADS) for Local Staging of Newly Diagnosed Bladder Cancer

Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2026年4月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
150
试验地点
1

研究概览

简要总结

This prospective diagnostic accuracy study compares computed tomography (CT) and multiparametric magnetic resonance imaging (MRI) using the Vesical Imaging-Reporting and Data System (VI-RADS) for local staging of newly diagnosed bladder cancer. All participants undergo both imaging modalities prior to transurethral resection of the bladder tumor (TURBT) or cystectomy. Histopathology serves as the reference standard.

详细描述

Accurate local staging is crucial for distinguishing non-muscle-invasive from muscle-invasive bladder cancer and guiding treatment decisions. While CT is widely used in clinical practice, MRI with VI-RADS has demonstrated higher diagnostic performance in previous retrospective and meta-analytic studies. However, prospective paired comparisons in the same patients are limited.

In this single-center prospective study, newly diagnosed bladder cancer patients undergo cystoscopy, contrast-enhanced CT, and multiparametric MRI prior to definitive histopathological sampling. Two radiologists independently assess imaging in a blinded research setting. Diagnostic performance of MRI and CT is compared using paired statistical analyses, with additional evaluation of interobserver agreement and tumor characteristics.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Newly diagnosed bladder cancer on cystoscopy
  • Planned TURBT or cystectomy within 6 weeks
  • Eligible for both CT and MRI within 6 weeks
  • Written informed consent provided

排除标准

  • Contraindications to MRI or iodinated contrast media
  • Prior treatment for bladder cancer
  • Pregnancy
  • Non-malignant bladder lesions
  • Tumors located in bladder diverticula

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andreas Habberstad

Principal Investigator

Oslo University Hospital

研究点 (1)

Loading locations...

相似试验